Monod Bio, Inc. — Form D
Monod Bio, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-24. The offering totals $26.3M, of which $24.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-06-24
- Form: D
- Accession: 0001897839-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $26.3M
- Amount sold: $24.2M
- Remaining: $2.0M
- Investors: 31
- Date of first sale: 2022-06-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-450212
Issuer
- Name: Monod Bio, Inc.
- CIK: 0001897839
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: FLUKE HALL - UW, SEATTLE, WA, 98105
- Phone: (206) 822-1255
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Berta Melina Cimler | Director | Seattle, WA |
| Dave Adriano Johnson | Director | Seattle, WA |
| David A Shoultz | Director | Seattle, WA |
| Daniel Adriano Silva Manzano | Director | Seattle, WA |
| Karan A Takhar | Director | Seattle, WA |
| Alfredo A Quijano Rubio | Executive Officer | Seattle, WA |
| David A Shoultz | Executive Officer | Seattle, WA |
| Daniel Adriano Silva Manzano | Executive Officer | Seattle, WA |
| Dave Melina Johnson | Director | Seattle, WA |
| David Melina Shoultz | Director | Seattle, WA |
| David Melina Shoultz | Executive Officer | Seattle, WA |
| Alfredo Quijano Rubio | Executive Officer | Seattle, WA |
Other filings by this issuer (1)
More